An aqueous extract of herbal medicine alwps enhances cognitive performance and inhibits lps-induced neuroinflammation via fak/nf-κb signaling pathways

15Citations
Citations of this article
30Readers
Mendeley users who have this article in their library.

Abstract

Recent studies have shown that Liuwei Dihuang pills (LWPs) can positively affect learning, memory and neurogenesis. However, the underlying molecular mechanisms are not understood. In the present study, we developed ALWPs, a mixture of Antler and LWPs, and investigated whether ALWPs can affect neuroinflammatory responses. We found that ALWPs (500 µg/ml) inhibited lipopolysaccharide (LPS)induced proinflammatory cytokine IL-1β mRNA levels in BV2 microglial cells but not primary astrocytes. ALWPs significantly reduced LPS-induced cell-surface levels of TLR4 to alter neuroinflammation. An examination of the molecular mechanisms by which ALWPs regulate the LPS-induced proinflammatory response revealed that ALWPs significantly downregulated LPS-induced levels of FAK phosphorylation, suggesting that ALWPs modulate FAK signaling to alter LPS-induced IL-1β levels. In addition, treatment with ALWPs followed by LPS resulted in decreased levels of the transcription factor NF-κB in the nucleus compared with LPS alone. Moreover, ALWPs significantly suppressed LPS-induced BV2 microglial cell migration. To examine whether ALWPs modulate learning and memory in vivo, wild-type C57BL/6J mice were orally administered ALWPs (200 mg/kg) or PBS daily for 3 days, intraperitoneally injected (i.p.) with LPS (250 µg/kg) or PBS, and assessed in Y maze and NOR tests. We observed that oral administration of ALWPs to LPS-injected wild-type C57BL/6J mice significantly rescued short-and long-term memory. More importantly, oral administration of ALWPs to LPS-injected wild-type C57BL/6J mice significantly reduced microglial activation in the hippocampus and cortex. Taken together, our results suggest that ALWPs can suppress neuroinflammation-associated cognitive deficits and that ALWPs have potential as a drug for neuroinflammation/neurodegeneration-related diseases, including Alzheimer’s disease (AD).

Author supplied keywords

References Powered by Scopus

Neuroinflammation in Alzheimer's disease

4352Citations
N/AReaders
Get full text

The nuclear factor NF-kappaB pathway in inflammation.

3920Citations
N/AReaders
Get full text

Microglia: A sensor for pathological events in the CNS

3891Citations
N/AReaders
Get full text

Cited by Powered by Scopus

Near-infrared II emissive metal clusters: From atom physics to biomedicine

56Citations
N/AReaders
Get full text

The involvement of renin-angiotensin system in lipopolysaccharide-induced behavioral changes, neuroinflammation, and disturbed insulin signaling

36Citations
N/AReaders
Get full text

The novel DYRK1A inhibitor KVN93 regulates cognitive function, amyloid-beta pathology, and neuroinflammation

24Citations
N/AReaders
Get full text

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Cite

CITATION STYLE

APA

Lee, J. Y., Joo, B., Nam, J. H., Nam, H. Y., Lee, W., Nam, Y., … Hoe, H. S. (2018). An aqueous extract of herbal medicine alwps enhances cognitive performance and inhibits lps-induced neuroinflammation via fak/nf-κb signaling pathways. Frontiers in Aging Neuroscience, 10, 1–19. https://doi.org/10.3389/fnagi.2018.00269

Readers' Seniority

Tooltip

PhD / Post grad / Masters / Doc 12

67%

Professor / Associate Prof. 2

11%

Lecturer / Post doc 2

11%

Researcher 2

11%

Readers' Discipline

Tooltip

Neuroscience 6

38%

Medicine and Dentistry 4

25%

Pharmacology, Toxicology and Pharmaceut... 3

19%

Immunology and Microbiology 3

19%

Save time finding and organizing research with Mendeley

Sign up for free